Pharmaceutical Manufacturing Equipment Market

Pharmaceutical Manufacturing Equipment Companies - GEA Group Aktiengesellschaft (GEA Group) (Germany) and I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A (Italy) are the Key Players

The pharmaceutical manufacturing equipment market is estimated to be worth USD 14.5 billion in 2023 and is projected to reach USD 19.7 billion by 2028, at a CAGR of 6.3% during the forecast period. The constantly growing demand for generics, the rising number of regulatory frameworks and guidelines for ensuring quality, and the growing necessity for adopting flexible pharmaceutical manufacturing are key factors contributing to the market growth.

Pharmaceutical Manufacturing Equipment companies include:

  • GEA Group Aktiengesellschaft (Germany),
  • I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy),
  • Syntegon Technology GmbH (Germany),
  • ACG (India), and
  • Thermo Fisher Scientific Inc.(US).

The market players have adopted various strategies such as development of advanced products, partnerships, collaborations, agreements, joint ventures, and acquisitions to strengthen their position in the pharmaceutical manufacturing equipment market. The organic and inorganic strategies have helped the market players to expand themselves globally by providing advanced solutions for pharmaceutical manufacturing equipment.

To know about the assumptions considered for the study download the pdf brochure

GEA Group Aktiengesellschaft (GEA Group) (Germany) is a leading German technology company specializing in machinery, equipment, process technology, and components. It provides equipment and solutions for various industries such as pharmaceutical, healthcare, food & beverage, chemical, dairy, environment, heating & refrigeration, marine, home & personal care, oil & gas, energy, etc. GEA Group Aktiengesellschaft is one of the largest suppliers of systems and components to food, beverage, pharmaceutical, and a wide range of processing industries. The company operates through five divisions: Separation & Flow Technologies, Liquid & Powder Technologies, Food & Healthcare Technologies, Farm Technologies, and Heating & Refrigeration Technologies. GEA Group Aktiengesellschaft offers a range of pharmaceutical manufacturing equipment and solutions to assist pharmaceutical firms in streamlining their manufacturing procedures, boosting productivity, and adhering to regulatory standards. Its pharmaceutical manufacturing equipment portfolio includes machines for granulation, coating, tableting, freeze-drying, liquid processing, and sterile and aseptic filling systems. Its equipment and solutions are used to manufacture a wide range of pharmaceutical products, including tablets, capsules, injectables, and lyophilized products. The pharmaceutical machinery from GEA is made to specifically fulfill the demands of the sector, which requires highly accurate, exact, and consistent manufacturing procedures. GEA Group Aktiengesellschaft has a geographical presence in North America, Western Europe, Latin America, Middle East & Africa, North & Central Europe, Eastern Europe, and Asia Pacific.

I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A (Italy) also known as IMA Group. It is an Italy-based company engaged in designing and manufacturing automatic machines for processing and packaging pharmaceuticals, cosmetics, food, tea, coffee, and other consumer goods. I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A operates in several business segments, including Pharma, Tea, Coffee and Beverage, Food & Dairy, Personal & Home Care, Tobacco, Automation, Tissue & Nonwoven, and Service. The company offers equipment for tableting, granulation, capsule tableting, capsule binding, coating, freeze drying, labeling, aseptic process, filling, washing, managing, and more through its Pharma division. The company also provides after-sales services and technical support to its customers, ensuring an effective maintenance schedule for improving productivity. The player strongly focuses on innovation, investing heavily in research and development to create new technologies and strengthen its existing product range. I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A operates in more than 80 countries, supported by a sales network of 29 branches and 53 manufacturing sites. The company serves North America, Europe, and Asia Pacific.

Syntegon Technology GmbH (Syntegon) (Germany) is one of the global leaders in manufacturing processors and packaging equipment for the pharmaceutical and food industries. In January 2020, Bosch (Germany) announced the sale of its Bosch packaging technology to CVC Capital Partners, which is managing Syntegon as a newly incorporated entity. Syntegon Technology GmbH operates in five segments Pharma, Food, MedTech, Nutraceuticals, and Services. Under the Pharmaceutical packaging and processing sub-division of the Pharma segment, Syntegon provides a broad portfolio of manufacturing equipment for formulation, processing, sterilization, fill-finish, mixing, and freeze-drying. It also offers barrier systems and inspection for liquid pharmaceuticals to processing, capsule filling, tablet pressing, and coating for oral solid dosage (OSD) forms and extensive customer services; the global network of experts supports customers throughout the entire machine lifecycle, from spare parts management to digital line optimization. Service agreements are a crucial element of the company’s portfolio. Syntegon employs around 5800 people at more than 30 locations in almost 20 countries across Europe, Asia Pacific, America, and Middle East/Africa. The company manages eight subsidiary companies, including Ampack GmbH, Huttlin GmbH, Kliklok, Makat Candy Technology, Osgood Industries, LLC, Pharmatec, SBM Schoeller-Bleckmann Medizintechnik, and Valicare.

ACG (India) is a global pharmaceutical solution provider offering manufacturing and packaging solutions for the pharmaceutical and nutraceutical industries. It provides a range of products and services, including capsule manufacturing, packaging solutions, films and foils, inspection systems, and engineering solutions. ACG operates in four business divisions: Capsules, Engineering, Films & Foils, and Inspection. Under the Engineering division, the company provides engineering solutions and services to pharmaceutical and nutraceutical manufacturing companies, including process automation, integrated manufacturing, and packaging solutions. The company offers a variety of pharmaceutical manufacturing equipment for several applications, including granulation, encapsulation, tableting, coating, and primary and secondary packaging. Under the Inspection division, the company offers a specialized business segment that provides advanced vision inspection solutions for pharmaceutical manufacturers, including blister, tablet, and high-speed bottle inspection. At the same time, the Capsule business division of the company manufactures empty hard gelatine capsules for the pharmaceutical, nutraceutical, and dietary supplement industries. The Films and Foils business division offers packaging materials such as blister foils, cold-form foils, child-resistant foils, laminates, and heat-seal coatings for the pharmaceutical industry. The company manages a network of 15 manufacturing facilities and 10 offices globally. It has a geographical presence in over 138 countries across six continents, including North America, South America, Asia, and Europe.

Thermo Fisher Scientific Inc. (US) is a multinational corporation that provides a range of scientific research and testing services, as well as laboratory equipment and consumables, to various industries. The company was formed in 1956 through the merger of Thermo Electron and Fisher Scientific, headquartered in Waltham, Massachusetts. In 2018, Thermo Fisher Scientific announced signing an agreement with Becton, Dickinson and Company (BDX) (US) to acquire the Advanced Bioprocessing business of Thermo Fisher. The company serves pharmaceutical and biotech companies; academic and research institutions, clinical diagnostic labs, and government agencies; and environmental, industrial quality, and process control sectors. Thermo Fisher Scientific Inc. operates through four main business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Under the Analytical Instruments and Laboratory Product and Biopharma Services segment, the company provides various analytical instruments, software, services, and consumables for pharmaceutical, biotechnology, environmental, and industrial applications. Thermo Fisher Scientific Inc. offers its products through numerous industry-leading brand names, such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. The company operates in over 70 countries worldwide, across multiple regions, including North America, Europe, and Asia Pacific.

Related Reports:

Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Mixing & Blending, Filling, Milling, Spray Drying, Inspection, Extrusion, Tablet Compression Presses), End-Product Type (Solid, Liquid) and Region - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Pharmaceutical Manufacturing Equipment Market Size,  Share & Growth Report
Report Code
SE 8645
RI Published ON
5/17/2023
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status